Role of Cyp2j-epoxygenases, sEH and PPARs in adenosine-induced vascular response
Role of Cyp2j-epoxygenases, sEH and PPARs in adenosine-induced vascular response
批准号:
9185998
负责人:
Mohammed A Nayeem
金额:
$37.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-01 至 2021-06-30
关键词:
ADORA2A geneAcetylcholineAdenosineAdenosine A1 ReceptorAdenylate CyclaseAffectAgonistAnti-Inflammatory AgentsAnti-inflammatoryAortaBathingBlood PressureBlood VesselsCardiovascular DiseasesCell LineCell physiologyClinicalCoronary arteryCountryCouplingCyclic AMP-Dependent Protein KinasesDataDevelopmentDown-RegulationDrug DesignEndothelial CellsEndotheliumEpoxide hydrolaseExerciseExhibitsExperimental DesignsG-substrateGTP-Binding ProteinsGenesGenetic PolymorphismGoalsHumanHypertensionIndividualKidneyLinkMeasuresMediatingMitogen-Activated Protein Kinase InhibitorMusMyocardial perfusionOrganOutcomePKA inhibitorPPAR PathwayPatientsPeroxisome Proliferator-Activated ReceptorsPharmaceutical PreparationsPharmacologyPopulationPreventionPublishingPurinergic P1 ReceptorsReceptor GeneRelaxationReportingResearchReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSmooth Muscle MyocytesTechnologyTestingTherapeutic UsesTransgenic MiceVascular EndotheliumVasodilationWestern BlottingWild Type Mousebaseblood pressure regulationdrinking waterendothelial dysfunctiongenetic variantinhibitor/antagonistinnovationknockout genemRNA Expressionnew therapeutic targetnoveloverexpressionperfusion imagingprotein expressionpublic health relevancerenal arteryresponsetoolvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Endothelial dysfunction is associated with corresponding changes in vascular tone and increases in contractility, a condition that may cause hypertension in susceptible individuals which may have allelic variants in cyp2j-epoxygenases, soluble epoxide hydrolase (sEH), A2A, and A1 adenosine receptors (A2A AR & A1 AR) genes. These allelic variants may have similarities to our transgenic mice which may regulate vascular tone and blood pressure (BP). Our preliminary data have suggested a possible link between adenosine-induced relaxation and opening of KATP channels through A2A AR-cyp2j-PKA-PPAR? pathway. Also, it is possible that a link may exist between adenosine-induced contraction and closing of KATP channels through A1 AR-sEH-cyp4a- PPAR� pathway. A combination of pharmacological tools and transgenic mice would allow us to identify the possible targets as a long term goal to treat population which may have allelic variants leading to hypertension. Therefore, there is a critical need to explore the possible mechanism involving cyp2j2-epoxygenases, sEH/cyp4a, A1 AR/A2A AR, PPAR�/?, PKA/PKC�/� and KATP channels in adenosine-induced vascular responses. Our central hypothesis is that adenosine induces vascular relaxation and decreases in BP through cyp2j-epoxygenases via A2A AR-cyp2j-PKA-PPAR? signaling leading to opening of KATP channels. On the other hand, adenosine induces vascular contraction and increases in BP through sEH via A1 AR-sEH-cyp4a-PPAR� pathway leading to closing of KATP channels. To test this hypothesis, we propose to explore in depth mechanism(s) using A2A AR-/-, A1 AR-/-, cyp2j5-/-, sEH-/-, Tie2-cyp2j2Tr (endothelial-cyp2j2 overexpressed), Tie2-sEHTr (endothelial-sEH overexpressed), wild-type mice, immortal renal endothelial cell line from H-2Kb- tsA58 mouse, mouse aortic endothelial cells (MAEC) and mouse aortic smooth muscle cells (MASMC). Further, we will also explore the possible treatment with sEH inhibitors (AUDA/t-AUCB) in drinking water (or gavage) for A2A AR-/-, cyp2j5-/- and Tie2-sEHTr mice which may have high BP. We will measure BP, and we will use aortas/renal arteries (organ bath/DMT-wire myograph) with treatments (adenosine-receptors agonists & antagonists), cyp-epoxygenases, sEH, adenylyl cyclase, PKC�/�/, MAPK and PKA inhibitors, PPAR�/?, EETs and KATP channel (activators & inhibitors). EETs & DHETs will be analyzed (UPLC-MS/MS). Western blot & RT-PCR will be used for proteins & mRNA expression. We propose 3 specific aims to determine: (1) whether the cyp2j-epxygenases or sEH affects BP, adenosine-induced vascular response and EETs/DHETs; (2) whether the presence or absence of A2A AR affects adenosine-induced vascular response through PPARs via cyp2j-epoxygenases, sEH (3) whether the presence /overexpression of cyp2j-epoxygenases or sEH regulate KATP channels through A2A AR-cyp2j-PKA-PPAR?/A1 AR-sEH-cyp4a-PPAR� pathway in adenosine-induced vascular response. Such results can have a positive impact, as the identified components are expected to provide new targets to curb clinical problems linked with dysfunctional endothelium leading to hypertension.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0169584
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Nayeem MA]
通讯作者:
Nayeem MA
Drug Delivery and Nanoformulations for the Cardiovascular System.
心血管系统的药物输送和纳米制剂。
DOI:
--
发表时间:
2017
期刊:
Research & reviews. Drug delivery
影响因子:
--
作者:
[Geldenhuys,WJ, Khayat,MT, Yun,J, Nayeem,MA]
通讯作者:
Nayeem,MA
DOI:
10.1371/journal.pone.0174137
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Nayeem MA]
通讯作者:
Nayeem MA
Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
探索腺苷受体配体:在心血管疾病治疗中的潜在作用。
DOI:
10.3390/molecules22060917
发表时间:
2017-06-01
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
[Geldenhuys WJ, Hanif A, Yun J, Nayeem MA]
通讯作者:
Nayeem MA
DOI:
10.1371/journal.pone.0162147
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Hanif A, Edin ML, Zeldin DC, Morisseau C, Nayeem MA]
通讯作者:
Nayeem MA
共 6 条
Role of Cyp2j-epoxygenases, sEH and PPARs in adenosine-induced vascular response
-
批准号:8666036
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2013
-
负责人:Mohammed A Nayeem
-
依托单位:
Role of Cyp2j-epoxygenases, sEH and PPARs in adenosine-induced vascular response
-
批准号:8501948
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2013
-
负责人:Mohammed A Nayeem
-
依托单位:
Role of Cyp2j-epoxygenases, sEH and PPARs in adenosine-induced vascular response
-
批准号:8989147
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2013
-
负责人:Mohammed A Nayeem
-
依托单位:
海外基金